Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL

Clinical trial NCT00577161 · WITHDRAWN

Trial details

NCT number: NCT00577161
Sponsor: CTI BioPharma
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma

Start date: 2007-09-01
Primary completion: 2012-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.